Stay updated on Vemurafenib Combo in High-Risk Melanoma Clinical Trial
Sign up to get notified when there's something new on the Vemurafenib Combo in High-Risk Melanoma Clinical Trial page.

Latest updates to the Vemurafenib Combo in High-Risk Melanoma Clinical Trial page
- Check2 days agoChange DetectedThe history shows the trial is no longer enrolling and introduces a new revision label v3.6.0, while the old revision label v3.5.5 is removed.SummaryDifference0.3%

- Check9 days agoChange DetectedA new revision entry v3.5.5 was added to the record history, and the previous v3.5.4 entry was removed. This updates the page's version trail.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedA new revision entry labeled v3.5.4 was added to the page's history and the previous entry v3.5.3 was removed.SummaryDifference0.1%

- Check38 days agoChange DetectedUpdated the study record to Completed with Results Posted, including Adverse Events, Outcome Measures (Results), Participant Flow, and Recruitment/Study Status. The previous Active, not recruiting and Results Submitted entries were removed, reflecting the trial's completion and public availability of final data.SummaryDifference0.8%

- Check52 days agoChange DetectedThe page’s footer/interface version was updated from **Revision: v3.5.2** to **Revision: v3.5.3**.SummaryDifference0.1%

- Check60 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Vemurafenib Combo in High-Risk Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vemurafenib Combo in High-Risk Melanoma Clinical Trial page.